APTA — Aptamer Share News
0.000.00%
Last trade - 00:00- £9.88m
- £5.70m
- £1.54m
UK's Aptamer H1 revenue rises on new pharma contracts
Brief: Aptamer H1 EBIT GBP -1.238 Million
Interim Results and Notice of Investor Webinar
Proposed Placing, Subscription and Retail Offer
Launch of targeted radiopharmaceutical programme
Technical Feasibility for Pathogen Detector
Optimer® Technology in Launched Library Prep Kit
Contract wins and first cash licensing receipts
Confirms Cash Position Provides Runway Through June 2027
Trading update - Media comment and speculation
Brief: Aptamer Group Reports HY Revenue Of £0.83 Million
Half Year Trading Update
Aptamer signs licensing agreement with Alphazyme
Licensing agreement with Twist Bioscience
AGM Statement
Brief: Aptamer Group Says Full Year Revenue Expected To Exceed Prior Year
Strong contract wins build commercial momentum
New contract with top five pharma company
Posting of Annual Report and Notice of AGM